AZD7624, an inhaled P38 inhibitor for COPD, suppresses lipopolysaccharide-induced airway inflammation

Category Primary study
JournalAmerican Journal of Respiratory and Critical Care Medicine
Year 2015
This article has no abstract
Epistemonikos ID: 2b1f114ad768d910186338d56fa4641459c1eed9
First added on: Feb 07, 2025